Background. Von Wilebrand disease (vWD) is the most common inherited disorder of hemostasis. Bleeding in patients with von Wilebrand disease is a frequently reported complaint. Patients with inherited bleeding disorders are also in a large number of cases infected with hepatitis C virus (HCV). Studies showed an increased risk factor for intracerebral hemorrhage (ICH) in patients infected with HCV receiving the combination treatment. Case report. A 44-year old man reported to our Emergency Department with low back pain, headaches, neck pain, leg weakness and urinary retention. The neurological examination showed nuchal rigidity and spastic paraparesis. Thoracic spine MRI revealed a subacute subdural haematoma at T8-T11 level.
a prevalence from 0.6% to 1.2%. 2 Patients with vWD are prone to complain of different bleeding episodes like mucocutaneus bleeding, menorrhagia, gastrointestinal bleeding with angiodysplasia or excessive postsurgical bleeding. 1 The infection with hepatitis C virus (HCV) is a major comorbidity in patients affected by bleeding disorders, with a prevalence of 39% in vWD patients. 3 In patients with chronic HCV infection the combination therapy of pegylated interferon alpha-2b and ribavirin is becoming a standard treatment. 4 Recent studies suggested that patients with chronic HCV infection receiving combination therapy were more prone to develop an intracerebral haemorrhage (ICH), indicating
Introduction
Von Wilebrand disease (vWD) is an inherited bleeding disorder that results from quantitative and qualitative deficiencies of von Wilebrand factor (vWF), a glycoprotein with an essential role in primary and secondary hemostasis. 1 The physical examination showed blood pressure 100/60 mm Hg, pulse 88/min and body temperature of 37.7°C. The neurological examination showed nuchal rigidity and spastic paraparesis of the legs. The blood test revealed a platelet count of 89.000/mm 3 , a prothrombin time of 65% and a partial thromboplastin time of 54 s. Laboratory studies for vWD showed a factor VIII activity of 43% and a vWF activity (ristocetin factor) of 17%. A MRI of the thoracic spine revealed a high intensity signal in T1-and T2-weighted images (WI) extending from T8 to T11 that belonged to a dorsal subdural haematoma. There was no abnormal signal visible in the spinal cord ( Figure 1 ). The treatment was conservative and cryoprecipitates were administered according to the level of factor VIII and vWF activity. The antiviral combination therapy was withdrawn. The patient responded well to our therapy and physiotherapy treatment followed after the initial mobilization.
After a month, on discharge from our centre, the patient was able to sit independently and his neurological improvement was satisfactory. On a follow-up MRI scan done 3 months after he reported to our ED there was a complete regression of the subdural hematoma and the neurological examination was normal.
Discussion
Acute SSDH is a rare condition that may result from iatrogenic factors, but also from coagulopathies, anticoagulant therapy, severe liver failure, underlying neoplasm, arteriovenous malformations or after poisoning with rodenticides of the coumarin group. [8] [9] [10] It usually presents with acute back pain and signs of spinal cord and cauda equina compression. Bleeding episodes often accompany vWD, but they rarely lead to the formation of a hematoma. 1 In two a possible association between HCV, HCV treatment and ICH. 5, 6 Spinal subdural hematoma (SSDH) is a rare condition that can lead to spinal cord or cauda equina compression. 7 A variety of causes, like bleeding disorders, anticoagulant therapy, arteriovenous malformations or underlying neoplasm have been described as possible pathogenic factors that could promote the formation of an acute SSDH. 8 Therefore, SSDH is a neurological and neurosurgical emergency that has to be promptly diagnosed and treated in order to provide the best possible recovery.
We report on a 44-year old man with vWD and chronic HCV receiving the combination therapy that developed sudden leg weakness and low back pain as the initial presentation of spontaneous acute SSDH. The diagnosis was confirmed by MRI and the patient was treated with a conservative approach.
Here we discuss the clinical features, imaging findings, treatment decision and outcome.
Case report
A 44-year old man reported to our Emergency Department (ED) with acute low back pain, headaches, neck pain, leg weakness and urinary retention. During the last two days before he reported to our ED, the patient had high body temperature. Since childhood, he was diagnosed vWD. He was serologically diagnosed as infected with HCV in 1999, and had been treated with the combination therapy of pegylated interferon alpha-2b and ribavirin for a period of five months before he reported to our ED. A month and a half before this episode, he was admitted to our Gastroenterology Department because of a bleeding duodenal ulcer. There was no history of trauma. a hematoma in the subacute phase. The epidural fat was well delineated, a fact that confirms the subdural location of the hematoma. Follow-up MRI scans were done in order to asses the evolution of the hematoma, that in our case in a 3 months period showed a complete regression, and to look for possible long term complications represented by arachnoidal fibrosis or spinal cord atrophy. 10 The current literature suggests three treatment options in case of a subdural hematoma: surgical decompression, percutaneous clot drainage and conservative treatment. 9, 10, 14 In a previous case of a subdural hematoma in a patient with idiopathic thrombocytopenic purpura a conservative approach was preferred, because of a significant risk of bleeding. 16 Because our patient was diagnosed with vWD, a factor that could promote bleeding complications during a surgical procedure, we opted for a conservative treatment.
Reviewing the literature regarding spinal hematoma and vWD, Kakazu et al. 17 reported of a spontaneous spinal epidural haemcases, patients with vWD reported with a subgaleal hematoma and an encapsulated hematoma of the thigh, both of them occurring after a trauma. 11, 12 Our patient with SSDH and vWD did not have any recent history of trauma, but he was on combination therapy for chronic HCV infection. Recent studies and case reports suggested that HCV infection alone or with combination therapy raised the possibility to develop an ICH. 5, 6, 13 Taking this in consideration, we could hypothesize that chronic HCV infection and combination therapy could be a risk factor to develop SSDH. Therefore, we decided to withdraw the antiviral combination therapy from his treatment.
MRI is the imaging method of choice to determine the location, evolution, extent and shape of the hematoma, as well as the follow-up of the patient like at the patients with the others causes of spine cord compresion. 9, 10, 14, 15 Our patient had a dorsal hematoma, with a crescent shape, extending from T8 to T11 and a high intensity signal in T1-and T2-weighted images indicating 
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orrhage associated with vWD. Therefore, to the best of our knowledge, this is the first report of a subdural hematoma of the thoracic spine in a patient with vWD and chronic HCV infection under the combination therapy. Our patient had an indicative clinical presentation, the diagnosis was confirmed by MRI and we decide to pursue a conservative treatment approach. We withdrew the antiviral combination therapy because of the possibility that it could be a risk factor for spontaneous bleeding. After three months, our patient showed a complete recovery.
